Machine learning was used to develop a simple prostate cancer-specific cardiovascular risk score using information already available in oncology clinic (age being the heavy hitter) to help identify men who warrant early cardiovascular optimization or cardio-oncology referral before initiating potentially cardiotoxic therapies such as ADT. | Stabellini, JCO Oncol Pract 2026
